Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors. - Wikidata - awgldk - TriplyDB

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors.

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors.

http://www.wikidata.org/entity/Q37314269

about

Clinical utility of lanreotide Autogel® in gastroenteropancreatic neuroendocrine tumors Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects.

P2860

Q28069632-671511DC-C463-4EA8-B567-D4FBCB78A9AA Q50079728-FB32737D-D222-4A67-B88D-2AA227531F46

P2860

Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors.

http://www.wikidata.org/entity/Q37314269

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Proteomics Suggests a Role for ...... ment of Neuroendocrine Tumors.

@en

Proteomics Suggests a Role for ...... ment of Neuroendocrine Tumors.

@nl

type

label

Proteomics Suggests a Role for ...... ment of Neuroendocrine Tumors.

@en

Proteomics Suggests a Role for ...... ment of Neuroendocrine Tumors.

@nl

prefLabel

Proteomics Suggests a Role for ...... ment of Neuroendocrine Tumors.

@en

Proteomics Suggests a Role for ...... ment of Neuroendocrine Tumors.

@nl

P1433

Q37314269-8CFD430C-CF67-4363-B3B3-94269F0D2377

P1476

Q37314269-2B6C314E-C061-487E-9404-A9EBFB4282A8

P2093

Q37314269-06684A1F-ED1E-4406-9120-5E5E00058582

Q37314269-13EEB662-1342-46CF-B638-F3F7E99D018F

Q37314269-184E8102-5AC6-445B-93E4-A9AC8675D754

Q37314269-1DBED7FC-224B-4B35-85C7-529C07ADDA06

Q37314269-302ABAB0-C798-4E85-AD83-AF8DAF0D079D

Q37314269-30EC04A3-79DF-48E2-84FA-22DDBDB9D86B

Q37314269-5DC2C830-CBBD-437B-8B16-25C92D0138AC

Q37314269-9166579C-ADC7-4DAD-845A-5BF448BD290C

Q37314269-B88217CE-FA0A-47F6-B3AE-198D66963354

Q37314269-BD0D4369-8F2D-4182-819E-B00C78AFBC82

P2860

Q37314269-061A4259-489C-4CC6-AFDA-9E2C10C79889

Q37314269-0979152B-4CCC-49D2-8EB4-F4B877F5DC8C

Q37314269-0EEC217F-DF01-4758-A75C-1087935D7C69

Q37314269-0F5741BE-EBC0-40EF-A918-FFB1ADCD27FF

Q37314269-10F3CBF2-74A3-4F13-8A54-892FA6D60657

Q37314269-1F227013-69EE-4ABB-A289-190007FFF7CD

Q37314269-1FC4BF55-183C-4AFD-8AF8-232C227A2F5A

Q37314269-223E432F-6D8C-453F-BED7-5C877D615B88

Q37314269-226F238C-A9B7-4AE7-9887-124983D22975

Q37314269-2584C136-2E06-4F71-AEC0-9F5AE4AF557A

P304

Q37314269-37CE4F50-1A77-457D-A718-F0F95AF36D6B

P31

Q37314269-878BCF47-6875-4FF8-B5EA-9AC7945CF1FA

P356

Q37314269-2452FF6B-0DDE-400C-B64B-97B2DBD24B70

P407

Q37314269-DEDA4827-02A0-4E87-AD2F-626FBB48D0B7

P433

Q37314269-F60AE85F-FB90-47E9-9CA8-C225C0C0C15B

P478

Q37314269-77472575-1446-47FC-AEAF-54674DA8C081

P50

Q37314269-1B7DAABB-8B1C-46AE-A2F5-655C5123B868

Q37314269-9F0EE26C-EB54-4B2F-A94A-F3AD9F0AF293

Q37314269-F8FB2449-5FF6-46D9-923A-5070E67198DD

P577

Q37314269-51C755EC-CC81-4AA6-B148-FEB513BE1653

P698

Q37314269-1B65F42B-6006-4F55-8C8B-EEDF411B47BC

P932

Q37314269-F06491CB-5935-441A-BA1E-83C7E3145B41

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Proteomics Suggests a Role for ...... ment of Neuroendocrine Tumors.

@en

P2093

Anders Höög

http://www.w3.org/2001/XMLSchema#string

Angela Lamarca

http://www.w3.org/2001/XMLSchema#string

C Christofer Juhlin

http://www.w3.org/2001/XMLSchema#string

Catharina Larsson

http://www.w3.org/2001/XMLSchema#string

Hanna Kjellin

http://www.w3.org/2001/XMLSchema#string

Jamileh Hashemi

http://www.w3.org/2001/XMLSchema#string

Jan Zedenius

http://www.w3.org/2001/XMLSchema#string

Magnus Kjellman

http://www.w3.org/2001/XMLSchema#string

Marta Mendiola

http://www.w3.org/2001/XMLSchema#string

Ming Lu

http://www.w3.org/2001/XMLSchema#string

P2860

PRAK is essential for ras-induced senescence and tumor suppression

Identification of c-MYC as a target of the APC pathway

Aurora kinases as prognostic biomarkers in ovarian carcinoma.

Survivin mediates resistance to antiandrogen therapy in prostate cancer

Lanreotide in metastatic enteropancreatic neuroendocrine tumors

Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues

Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.

Genomic organization, 5'-upstream sequence, and chromosomal localization of an insulinoma-associated intronless gene, IA-1.

Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients

SEOM clinical guidelines for the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) 2014

P304

3616-3627

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2016-2028

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Laura Guerra Pastrián

P577

2016-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27459532

http://www.w3.org/2001/XMLSchema#string

P932

5052342

http://www.w3.org/2001/XMLSchema#string